![Vanessa Lusitano Jacoby](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vanessa Lusitano Jacoby
Director of Finance/CFO at PharmAkea, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Bruce F. Scharschmidt | M | 78 |
PharmAkea, Inc.
![]() PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | - |
Kevin Holme | M | - |
PharmAkea, Inc.
![]() PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | 12 years |
Mervyn Turner | M | 77 |
PharmAkea, Inc.
![]() PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | - |
Christopher D. King | M | - |
PharmAkea, Inc.
![]() PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | - |
Rupert Vessey | M | 59 |
PharmAkea, Inc.
![]() PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | - |
Andrew Tager | M | - |
PharmAkea, Inc.
![]() PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Howard Hutchinson | M | - |
PharmAkea, Inc.
![]() PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | 5 years |
Robert Williamson | M | 58 |
PharmAkea, Inc.
![]() PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | 6 years |
Daren J. Barone | M | 59 |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 3 years |
Leonardo Morari | M | - |
Fundação Armando Alvares Penteado
| 4 years |
Dominick Anthony Zizzo | M | - |
National University
| 3 years |
Mituo Hirota | M | 79 |
Fundação Armando Alvares Penteado
| 17 years |
Rodrigo Geraldi Arruy | M | 46 |
Fundação Armando Alvares Penteado
| 4 years |
Cristina Hartmann Baldim | F | - |
Fundação Armando Alvares Penteado
| 4 years |
Alexander D. Henderson | M | 61 |
National University
| 2 years |
Wellington Donizetti Silverio | M | 54 |
Fundação Armando Alvares Penteado
| 1 years |
Muhammad Abbas | M | - |
National University
| 4 years |
Fábio Eliezer Figueiredo | M | 55 |
Fundação Armando Alvares Penteado
| 4 years |
Laurie H. Argo | F | 52 |
National University
| 2 years |
Ekman Tjandranegara | M | 49 |
National University
| 4 years |
Guilherme Stocco Filho | M | 56 |
Fundação Armando Alvares Penteado
| 4 years |
Guilherme Fontes Ribeiro | M | - |
Fundação Armando Alvares Penteado
| 4 years |
Eugênio Emílio Staub Filho | M | 52 |
Fundação Armando Alvares Penteado
| 4 years |
Maria Laura Tarnow | F | 54 |
Fundação Armando Alvares Penteado
| 1 years |
Daniel Arruda | M | - |
Fundação Armando Alvares Penteado
| 4 years |
João Eduardo de Azevedo Silva | M | 52 |
Fundação Armando Alvares Penteado
| 4 years |
Francisco José Ritondaro | M | 50 |
Fundação Armando Alvares Penteado
| 4 years |
Alexandre Lopes Dias | M | 50 |
Fundação Armando Alvares Penteado
| 4 years |
Lon E. Otremba | M | 67 |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 2 years |
Beverly A. Huss | F | 64 |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 6 years |
Susan A. Brodsky-Thalken | F | 71 |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 7 years |
Frank M. Fazio | M | 55 |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 7 years |
Adelbert L. Stagg | M | 77 |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 2 years |
Karon J. Morell | F | 74 |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | - |
Brandi Roberts | F | 50 |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 1 years |
John Costantino | M | 77 |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 7 years |
Christopher Reinhard | M | 70 |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 4 years |
Diane S. Goostree | F | 68 |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 2 years |
Stefan Lemperle | M | - |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 7 years |
Gregory J. Kricorian | M | 54 |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | - |
Bob B. Sherman | M | 81 |
Artes Medical, Inc.
![]() Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 4 years |
Pedro Jereissati | M | 46 |
Fundação Armando Alvares Penteado
| 4 years |
Ana Cristina Junqueira Pereira do Valle | F | 50 |
Fundação Armando Alvares Penteado
| 4 years |
Burkhard Otto Cordes | M | 49 |
Fundação Armando Alvares Penteado
| 4 years |
Kazi Khairul Alam | M | - |
National University
| 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 28 | 62.22% |
Brazil | 17 | 37.78% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Vanessa Lusitano Jacoby
- Personal Network